Latest filing published 29 May 2015 for OSIRIS THERAPEUTICS, INC., €81k.
No signal scores available.
Philip R. Jacoby Jr. appears in our data through filings on Osiris Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 February 2007 to 27 May 2015, the count stands at 18 filings.
The open-market record consists of 3 sales worth €737k, with no purchase. Besides market trades, the filings include 15 option exercises. Since January 2015: no purchases and 1 sale on the market.
On 29 May 2015 came the latest disclosure, an open-market sale for €340k in Osiris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations